Literature DB >> 28616370

Editorial Comment: Cost-Effectiveness Analysis for Prioritization of Limited Public Health Resources - Tuberculosis Interventions in Texas.

Kaja M Abbas1.   

Abstract

Public health departments have limited evidence to understand and analyze the costs and benefits of different health programs, including tuberculosis control and prevention programs. The study by Miller et. al addresses this challenge to estimate costs and benefits of tuberculosis prevention programs in Texas and identify cost-effective diagnostic and treatment combinations, thereby improving the evidence-based decision making power of the public health departments.

Entities:  

Keywords:  Cost-Effectiveness Analysis; Evidence-Based Policy and Practice; Public Health Services and Systems Research; Tuberculosis

Year:  2014        PMID: 28616370      PMCID: PMC5467536          DOI: 10.13023/FPHSSR.0302.04

Source DB:  PubMed          Journal:  Front Public Health Serv Syst Res        ISSN: 2169-1584


  4 in total

1.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

2.  Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis.

Authors:  David W Dowdy; Adithya Cattamanchi; Karen R Steingart; Madhukar Pai
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

3.  Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants.

Authors:  Travis C Porco; Bryan Lewis; Elliot Marseille; Jennifer Grinsdale; Jennifer M Flood; Sarah E Royce
Journal:  BMC Public Health       Date:  2006-06-19       Impact factor: 3.295

Review 4.  How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI.

Authors:  Olivia Oxlade; Marcia Pinto; Anete Trajman; Dick Menzies
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.